Featuring slide presentations and related discussion from Dr Nikhil I Khushalani, Dr Soo J Park, Dr Vishal Anil Patel and Dr Evan Wuthrick, including the following topics:

• Introduction (0:00)
• Current Management of Localized, Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) (9:55)
• Case: A man in his early 70s with cSCC who previously underwent surgery and adjuvant therapy (32:39)
• Case: A man in his early 60s with cSCC who receives cemiplimab (54:45)
• Incorporation of Radiation Therapy into the Multidisciplinary Management of cSCC and Basal Cell Carcinoma (BCC) (1:04:24)
• Case: A man in his early 70s with cSCC who receives radiation therapy after a surgeon expresses concern about the risks of surgery (1:22:15)
• Case: A man in his late 80s with cSCC who is not a candidate for surgery (1:24:09)
• Evidence-Based Treatment Strategies for Patients with BCC (1:26:00)
• Case: A man in his mid sixties with BCC who receives sonidegib (1:36:49)
• Case: A man in his late 70s with BCC who receives vismodegib (1:38:32)
• Dermatologic Care for Patients with cSCC and BCC (1:45:09)

CME information and select publications

Featuring an interview with Dr Hanny Al-Samkari, including the following topics:

• Case: A man in his early 40s with chronic immune thrombocytopenia (ITP) receives romiplostim with rituximab — Bhavana (Tina) Bhatnagar, DO (0:00)
• Case: A woman in her early 80s with metastatic adenocarcinoma of the lung responds to carboplatin/pemetrexed/pembrolizumab but after 14 months of maintenance pembrolizumab presents with ITP — Susmitha Apuri, MD (6:48)
• Case: A man in his late 70s with a 30-year history of chronic ITP who received corticosteroids and rituximab now receives avatrombopag — Sunil Gandhi, MD (12:06)
• Case: A woman in her early 80s with multiple comorbidities and a long history of ITP presents with confusion and fluid retention due to exacerbated congestive heart failure and receives fostamatinib — Dr Bhatnagar (19:26)

CME information and select publications

Featuring perspectives from Prof Karim Fizazi and Dr Daniel George, moderated by Dr Elisabeth I Heath, including the following topics:

• Introduction (0:00)
• Clinical Implications of and Appropriate Strategies to Identify PTEN Deficiency in Prostate Cancer — Dr George (3:25)
• Targeting AKT in Metastatic Prostate Cancer — Prof Fizazi (32:54)
• Tolerability and Other Practical Considerations with Capivasertib — Dr Heath (1:03:15)

CME information and select publications